Vivus Inc. (NASDAQ:VVUS) is having an absolutely awful day, with the stock down more than 13% after the company reported its Q4 results. The launch of its first-in-class obesity drug Qsymia was very highly anticipated among investors with the market potential being huge in this space, but sales just aren’t panning out that way. VIVUS, Inc. (NASDAQ:VVUS) stock opened at $5.77 in last session, and closed at $5.86, while the day range of stock is $5.77 – $6.24. The stock showed a negative weekly performance of -18.61%.
RealPage, Inc. (NASDAQ:RP)’s shares dropped 21.72% to $16.22. The company on Feb. 24 announced financial results for its fourth quarter and year ended December 31, 2013. Fourth quarter Non-GAAP total revenue was $96.4 million, an increase of 12.5% year-over-year, while GAAP total revenue was $95.5 million, an increase of 11.4% year-over-year. RealPage, Inc. (NASDAQ:RP) stock opened at $15.50, in last session and closed at $16.03, by losing -22.64%. The 52 week range of the stock is $15.40 – $26.34. Company’s market capitalization is $1.25 billion.
Williams Co. and Boardwalk Pipeline Partners (NYSE:BWP) are jointly proposing to build the line, which would run from Pennsylvania to Kentucky and connect with an existing pipeline to carry natural gas liquids to Louisiana. Boardwalk Pipeline Partners, LP (NYSE:BWP) stock decreased -1.03% and finished the last session at $12.50. The EPS of the stock remained 0.96. Company’s market capitalization is $2.76 billion.
Analysts at Cantor Fitzgerald dropped their target price on shares of Ventrus Biosciences (NASDAQ:VTUS) from $6.00 to $2.50 in a research report issued to clients and investors on Thursday,Analyst RN reports. Cantor Fitzgerald’s price objective would indicate a potential upside of 58.23% from the company’s current price. Ventrus Biosciences Inc (NASDAQ:VTUS) stock opened the session at $1.53, and closed the session at $1.46. The 52 week range of the stock remained $1.45 – $4.69 and the day range was $1.45 – $1.55.